Heron Therapeutics Insider Trades

HRTX

Track insider trading activity from Heron Therapeutics executives and directors. See which insiders are buying and selling HRTX stock.

Trades Last 12 Months

HRTX Price

All Insider Trades for Heron Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Collard Craig A Chief Executive Officer
Holding Value $242k 870,289 shares
Last Trade
Oct 19, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.1k 13,797 shares
$0.37
$0.28
Forbes William P Evp, Chief Development Officer
Holding Value $68k 245,047 shares
Last Trade
Oct 19, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.43k 3,874 shares
$0.37
$0.28
Duarte Ira Evp, Chief Financial Officer
Holding Value $79.4k 285,773 shares
Last Trade
Oct 19, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.43k 3,874 shares
$0.37
$0.28
Hensley Mark Earl Chief Operating Officer
Holding Value $47.5k 170,901 shares
Last Trade
Aug 06, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.44k 8,888 shares
$0.50
$0.28
Johnson Craig A Director
Holding Value $15k 53,960 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.2k 53,960 shares
$1.32
$0.28
Christian Waage Director
Holding Value $15k 53,960 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.2k 53,960 shares
$1.32
$0.28
Cusack Thomas Director
Holding Value $15k 53,960 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.2k 53,960 shares
$1.32
$0.28
Holding Value $15k 53,960 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.2k 53,960 shares
$1.32
$0.28
Morgan Adam Director
Holding Value $34.4k 123,737 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.2k 53,960 shares
$1.32
$0.28
Kaseta Michael Director
Holding Value $15k 53,960 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.2k 53,960 shares
$1.32
$0.28
Holding Value $0 0 shares
Last Trade
Oct 15, 2025 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$128k 94,610 shares
$1.35
$0.28
Rodriguez Susan Director
Holding Value $24.2k 87,180 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61k 35,900 shares
$1.70
$0.28
Peraza Lisa Vp, Chief Accounting Officer
Holding Value $11.4k 41,078 shares
Last Trade
Jan 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.9k 41,078 shares
$2.09
$0.28
Manhard Kimberly Evp, Drug Development
Holding Value $7.87k 28,330 shares
Last Trade
Apr 13, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.08k 1,417 shares
$2.88
$0.28
Quart Barry D Chief Executive Officer
Holding Value $236k 850,000 shares
Last Trade
Jan 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.66M 850,000 shares
$3.13
$0.28
Hoffman Robert CFO & Svp, Finance
Holding Value $27.8k 100,000 shares
Last Trade
Dec 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.5M 100,000 shares
$25.02
$0.28
Rosen Robert President
Holding Value $83.3k 300,000 shares
Last Trade
Dec 15, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.49M 300,000 shares
$24.97
$0.28
Drazba Brian G. Vp, Finance & CFO
Holding Value $1.05k 3,798 shares
Last Trade
Oct 31, 2016 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$7.99k 538 shares
$14.85
$0.28
Marshall Paul Svp, Technical Operations
Holding Value $11.9k 42,800 shares
Last Trade
Mar 21, 2016 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.8k 1,100 shares
$17.10
$0.28
Gelder Mark S. Md SVP & Chief Medical Officer
Holding Value $12.5k 45,000 shares
Last Trade
Dec 12, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$407k 45,000 shares
$9.05
$0.28

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up